MSB 2.03% $1.45 mesoblast limited

Regulatory Pathways - where we stand with the FDA, page-56

  1. 7,775 Posts.
    lightbulb Created with Sketch. 7032
    Wouldn't it be the other way around. If you believe J&J vaccine dodgy and cronyism/corruption at work, then its in J&J's interest to not block stem-cell treatments so its two have more likely pathways....?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.